Mary Gray

Mary Gray

Directeur/Membre du Conseil chez KEROS THERAPEUTICS, INC.

Fortune : 137 053 $ au 30/06/2026

73 ans
Health Technology
Finance
Consumer Services

Profil

Dr. Mary A. Gray is an Independent Director at Compass Therapeutics, Inc., an Independent Director at Keros Therapeutics, Inc., an Independent Director at BioAtla, Inc. and a President at Gray Strategic Advisors LLC.
She is on the Board of Directors at Compass Therapeutics, Inc., Keros Therapeutics, Inc. and BioAtla, Inc. Dr. Gray was previously employed as an Independent Director by Rapt Therapeutics, Inc., an Independent Director by Seneca Biopharma, Inc., an Independent Director by Palisade Bio, Inc., an Independent Director by Sarepta Therapeutics, Inc., an Independent Director by Juniper Pharmaceuticals, Inc., an Independent Director by TetraLogic Pharmaceuticals Corp., an Independent Director by ACADIA Pharmaceuticals, Inc., a Lead Independent Director by Dyax Corp., a Portfolio Manager by Wayne Hummer Investment Trust, a Fund Manager by Federated Investment Management Co., an Advisor by Burrill LLC, a Principal by Kidder Peabody, a Senior Scientist by Poniard Pharmaceuticals, Inc., a Principal by Raymond James & Associates, Inc., a Senior Scientist by Schering-Plough Corp., and a Principal by Warburg Dillon Read LLC.
She also served on the board at Galena Biopharma, Inc., Senomyx, Inc., Advanced Peptide Therapeutics, Inc., GTC Biotherapeutics, Inc. and Telik, Inc. She received her undergraduate degree from the University of South Carolina and a doctorate degree from the University of Vermont.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
03/06/2026 12 392 ( 0,06% ) 132 594 $ 30/06/2026
31/03/2026 1 077 ( 0,06% ) 4 459 $ 30/06/2026
31/03/2026 0 ( -.--% ) - $ 30/06/2026

Postes actifs de Mary Gray

SociétésPosteDébut
BIOATLA, INC. Directeur/Membre du Conseil 01/12/2020
KEROS THERAPEUTICS, INC. Directeur/Membre du Conseil 17/12/2020
COMPASS THERAPEUTICS, INC. Directeur/Membre du Conseil 25/04/2022
Gray Strategic Advisors LLC
Fondateur 01/09/2003

Anciens postes connus de Mary Gray

SociétésPosteFin
RAPT THERAPEUTICS, INC. Directeur/Membre du Conseil 03/03/2026
PALISADE BIO, INC. Directeur/Membre du Conseil 04/03/2024
SAREPTA THERAPEUTICS, INC. Directeur/Membre du Conseil 02/06/2022
SENOMYX INC. Directeur/Membre du Conseil 01/12/2018
JUNIPER PHARMACEUTICALS INC Directeur/Membre du Conseil 01/08/2018
Voir l'expérience en détail de Mary Gray

Formation de Mary Gray

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

65

Relations au 1er degré

27

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées27

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Consumer Non-Durables

Health Technology

Health Technology

Finance

Miscellaneous

Finance

Finance

Finance

Consumer Services

Consumer Services

Health Technology

Health Services

Gray Strategic Advisors LLC

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology